(PRWEB) November 13, 2012
Last week, Nolan Auerbach Partner Jeb White presented at the 13th Annual Pharmaceutical Regulatory & Compliance Congress, at the Grand Hyatt Hotel in Washington, D.C. During a plenary panel discussion of “leading qui tam counsel,” Mr. White discussed recent efforts to combat pharmaceutical fraud and outlined the pivotal role whistleblowers have played in False Claims Act recoveries against the pharmaceutical and medical device industries. The session was moderated by defense attorney Kirk Ogrosky, and Mr. White was joined by qui tam attorneys Michael Morse and Dan Miller. The audience included nearly 1,000 representatives from the pharmaceutical industry, including compliance officers and attorneys from across the country.
Mr. White is one of the country’s leading qui tam advocates, having represented whistleblowers before the United States Congress and in qui tam actions across the country against fraudulent hospital systems to dishonest pharmaceutical companies. As a trusted authority of the law, Mr. White has penned amicus curiae briefs in five United States Supreme Court cases, examining the federal False Claims Act, and he has been a constant source for Department of Justice and other officials in need of qui tam expertise. He has lectured over fifty times on the subjects of False Claims Act litigation and health care fraud schemes. Mr. White is the former President and current Board member of Taxpayers Against Fraud, a nonprofit public interest organization dedicated to combating fraud against the federal government. In 2012, he was the Co-Chairman of the ABA National Institute on Civil False Claims Act& Qui Tam Enforcement.